This research is focused on the molecular mechanisms that govern whether a primary breast cancer will or will not become aggressive, metastatic and thus life threatening. At present, the ability to predict such aggressiveness is imperfect, in that there is great inter-individual variability in the behavior of a group of tumors that are all classified together in one of the major subgroups of breast cancer and thus predicted to share a common prognosis. At present, this inability to generate accurate predictions of the future behavior of individual breast cancers leads to aggressive treatment of the great majority of diagnosed tumors, when only a minority are destined to become life threatening. The research describes three major determinants of malignant progression of breast cancer cells and how they conspire to generate aggressive behavior. These are (i) the ability of carcinoma cells to release pro-inflammatory signals; (ii) the reciprocal responses of nearby mesenchymal stem cells within the stroma of tumors to these carcinoma-derived signals, resulting secondarily in the release of signals that have the potential of inducing carcinoma cells to move from an epithelial(benign) to mesenchymal (malignant) state; and (iii) the propensity of the carcinoma cells to respond to these stroma-derived signals by undergoing this shift in differentiation state, thereby acquiring highly aggressive characteristics. The propensity of cancer cells to move from an epithelial/benign to a mesenchymal/malignant state appears to be governed by the state of the chromatin associated with the gene that encodes ZEB1, which functions as the key molecular governor of the epithelial vs. mesenchymal states. Examining the chromatin configuration of this gene- more specifically the covalent modifications of the histones associated with the promoter of this gene - holds the promise of revealing the proclivity of a breast cancer cell to activate its program of malignant conversion, often termed the epithelial-mesenchymal transition.

Public Health Relevance

This research is focused on the molecular mechanisms that determine whether or not a primary human breast cancer will become aggressive and metastatic, resulting in an ability to predict such future behavior. At present, the inability to predict this behavior results in the vast overtreatment of breast cancer patients, most of whom are treated with aggressive therapies even though the tumors that they bear are not destined to ever become life threatening.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA080111-20
Application #
9452889
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
20
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
120989983
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Rashidian, Mohammad; Ingram, Jessica R; Dougan, Michael et al. (2017) Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells. J Exp Med 214:2243-2255
Dreijerink, Koen M A; Timmers, H T Marc; Brown, Myles (2017) Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1. Endocr Relat Cancer 24:T135-T145
Hydbring, Per; Wang, Yinan; Fassl, Anne et al. (2017) Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers. Cancer Cell 31:576-590.e8
Bierie, Brian; Pierce, Sarah E; Kroeger, Cornelia et al. (2017) Integrin-?4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci U S A 114:E2337-E2346
Wang, Yu; Woehrstein, Johannes B; Donoghue, Noah et al. (2017) Rapid Sequential in Situ Multiplexing with DNA Exchange Imaging in Neuronal Cells and Tissues. Nano Lett 17:6131-6139
Dongre, Anushka; Rashidian, Mohammad; Reinhardt, Ferenc et al. (2017) Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. Cancer Res 77:3982-3989
Dreijerink, Koen M A; Groner, Anna C; Vos, Erica S M et al. (2017) Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer. Cell Rep 18:2359-2372
Wang, Haizhen; Nicolay, Brandon N; Chick, Joel M et al. (2017) The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature 546:426-430
Hydbring, Per; Wang, Yinan; Bogorad, Roman L et al. (2017) Identification of cell cycle-targeting microRNAs through genome-wide screens. Cell Cycle 16:2241-2248
Tavera-Mendoza, Luz E; Westerling, Thomas; Libby, Eric et al. (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proc Natl Acad Sci U S A 114:E2186-E2194

Showing the most recent 10 out of 127 publications